Kaye Scholer’s Life Sciences Industry Group is proud to host the NYC MedTech program on Thursday, September 13, at 5:15 p.m. at the Kaye Scholer offices in New York. NYC Medtech programs are private networking evenings featuring keynotes by important figures in the life sciences industry. This event connects early stage and emerging growth companies with private and strategic investors and other industry partners.
David Roth, Co-chair of Tick-Borne Disease Alliance (TBDA) and Managing Director of the Blackstone Real Estate Group
Mr. Roth will be speaking on the recent partnership between Tick Borne Diseases Alliance (TBDA) and the X PRIZE Foundation, “TBDA Diagnostic X PRIZE,” the first worldwide competition to develop a reliable diagnostic tool for Lyme and tick-borne diseases.
Eric Schadt, Ph. D., Director of The Institute for Genetics and Multiscale Biology at Mount Sinai School of Medicine
Mr. Schadt will be speaking on the Institute's revolutionary approach to understand the complexity of the human genome to defeat the most common human diseases.
For more information, please visit www.nycmedtech.com.
Kaye Scholer’s multidisciplinary Life Sciences Industry Group represents pharmaceutical, medical device and biotech companies on a full range of legal issues. From IP and patent litigation, product liability and antitrust to licensing, tech transfer, compliance and risk mitigation counseling, joint ventures and M&A transactions, life sciences is so deeply ingrained in our Firm’s DNA virtually every practice area provides counsel to our clients in this rapidly evolving industry.
September 13, 2012 5:15pm to 8:00pm